Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
108: An all-star panel discuss EIS & VCTs in 2024 and look forward to 2025
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Stellar Asset Management Limited/Nova Growth Capital Limited
Stellar Nova EIS Fund
By
Dr Brian Moretta
16 Nov 2021
Advanced Oncotherapy
Life Sciences
On the home straight
By
Dr Martin Hall
15 Nov 2021
The International Stock Exchange
Financials
Global, responsive, competitive
By
Jason Streets
09 Nov 2021
Real Estate Credit Investments (RECI)
Investment Companies
Why rising rates should not hurt RECI
By
Mark Thomas
08 Nov 2021
UK gas – caught short, caught very short?
By
Nigel Hawkins
04 Nov 2021
The Monthly: November 2021
By
Nigel Hawkins
01 Nov 2021
CyanConnode
Technology
1H’22 update: strong shipments and cash inflows
By
Milan Radia
20 Oct 2021
Tissue Regenix
Life Sciences
Faster-than-anticipated recovery
By
Dr Martin Hall
19 Oct 2021
City of London Investment Group
Investment Companies
Good performance offsets weak markets
By
Dr Brian Moretta
18 Oct 2021
WET
Utilities
Monetising its Water R&D
By
Nigel Hawkins
15 Oct 2021
Research reach and investor engagement
By
Keith Hiscock
15 Oct 2021
Prev
1
...
27
28
29
30
31
...
84
Next
